HYPD vs. NKTX, FATE, MCRB, GNLX, FTLF, TARA, KRRO, SKYE, ACTU, and ALTS
Should you be buying Hyperion DeFi stock or one of its competitors? The main competitors of Hyperion DeFi include Nkarta (NKTX), Fate Therapeutics (FATE), Seres Therapeutics (MCRB), Genelux (GNLX), FitLife Brands (FTLF), Protara Therapeutics (TARA), Korro Bio (KRRO), Skye Bioscience (SKYE), Actuate Therapeutics (ACTU), and ALT5 Sigma (ALTS). These companies are all part of the "pharmaceutical products" industry.
Hyperion DeFi vs. Its Competitors
Hyperion DeFi (NASDAQ:HYPD) and Nkarta (NASDAQ:NKTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.
In the previous week, Hyperion DeFi had 3 more articles in the media than Nkarta. MarketBeat recorded 4 mentions for Hyperion DeFi and 1 mentions for Nkarta. Nkarta's average media sentiment score of 1.83 beat Hyperion DeFi's score of 0.20 indicating that Nkarta is being referred to more favorably in the news media.
25.8% of Hyperion DeFi shares are owned by institutional investors. Comparatively, 80.5% of Nkarta shares are owned by institutional investors. 7.1% of Hyperion DeFi shares are owned by insiders. Comparatively, 8.4% of Nkarta shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Hyperion DeFi has higher revenue and earnings than Nkarta. Nkarta is trading at a lower price-to-earnings ratio than Hyperion DeFi, indicating that it is currently the more affordable of the two stocks.
Hyperion DeFi has a beta of 2.47, indicating that its share price is 147% more volatile than the S&P 500. Comparatively, Nkarta has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500.
Hyperion DeFi currently has a consensus target price of $2.00, indicating a potential downside of 87.27%. Nkarta has a consensus target price of $14.33, indicating a potential upside of 618.46%. Given Nkarta's stronger consensus rating and higher possible upside, analysts plainly believe Nkarta is more favorable than Hyperion DeFi.
Nkarta has a net margin of 0.00% compared to Hyperion DeFi's net margin of -62,238.41%. Hyperion DeFi's return on equity of 0.00% beat Nkarta's return on equity.
Summary
Nkarta beats Hyperion DeFi on 10 of the 16 factors compared between the two stocks.
Get Hyperion DeFi News Delivered to You Automatically
Sign up to receive the latest news and ratings for HYPD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HYPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hyperion DeFi Competitors List
Related Companies and Tools
This page (NASDAQ:HYPD) was last updated on 7/17/2025 by MarketBeat.com Staff
Free HYPD Stock Alerts